(PQC5)Early Detection Pancreatic Cancer by Hyperpolarized Silicon Nanoparticles

描述（由申请人提供）：胰腺癌患者预后不良的主要原因是80-90%的患者在诊断时患有不可切除的疾病。这项研究提案提供了一种策略，可以通过MRI检测胰腺癌，其数量级比目前通过采用靶向特异性超极化硅纳米颗粒检测到的数量级小至少两到三个数量级。这种策略在临床上成功引入后，将提高胰腺肿瘤发展早期的整体可检测性，并可能通过成功的手术干预挽救生命。在胰腺组织中产生的胰腺肿瘤生物标志物中，发现与正常胰腺相比，肝癌-肠-胰腺/胰腺炎相关蛋白（HIP/PAP）在胰腺癌中的胰腺腺泡细胞中过表达超过130倍。相反，慢性胰腺炎的腺泡细胞中HIP/PAP蛋白的表达仅增加9倍。这为胰腺癌中肿瘤和肿瘤间质相互作用的成像提供了独特的机会。这个探索性项目的目的是开发一种高度敏感的HIP/PAP靶向分子成像剂的基础上，一种新的硅超极化磁共振成像（MRI）技术最近在我的实验室开发。以前的生化研究表明，HIP/PAP蛋白是一种“乳糖结合蛋白”，对D-乳糖具有很高的亲和力。我们打算采用乳糖功能化的超极化硅纳米粒子（SiNP）靶向胰腺肿瘤周围腺泡细胞中的HIP/PAP蛋白。与常规MRI相比，超极化导致超过10，000倍的信号增强。我们假设，乳糖官能化的SiNP结合胰腺癌周围的HIP/PAP的特异性与由于超极化引起的灵敏度增益相结合，将导致“有效的病变尺寸放大”，从而使得胰腺癌在体内MRI中的可视化比目前检测到的那些小至少两到三个数量级。为此，我们提出以下三个具体目标：优化乳糖功能化硅纳米颗粒（SiNP）上的无自由基29 Si动态核极化可实现的超极化水平，作为SiNP尺寸和体内靶向功效的函数。二.在a）一种正交各向异性胰腺肿瘤异种移植小鼠模型和B）移植到NOD/SCID小鼠中的两个患者源性肿瘤队列（其中一个是未处理的人胰腺肿瘤，另一个暴露于新辅助治疗）中，用实时超极化MRI证明“有效的病变大小放大”。三.将目标II中获得的超极化29 Si MR数据与小鼠癌症模型中荧光标记SiNP的免疫组织化学和光学成像数据相关联，证明该技术在检测胰腺癌方面的有效性，比目前检测到的胰腺癌小至少两到三个数量级。

DESCRIPTION (provided by applicant): The primary reason for a poor prognosis for patients with pancreatic cancer is because 80-90% of patients have unresectable disease at the time of diagnosis. This research proposal offers a strategy that may enable the detection of pancreatic cancer by MRI with at least two to three orders of magnitude smaller than those currently detected by employing target specific hyperpolarized silicon nanoparticles. This strategy when successfully introduced in the clinic will improve the overall detectability of pancreatic tumors a early stages of their development and could potentially save lives by successful surgical interventions. Among pancreatic tumor biomarkers produced in pancreatic tissue, the hepatocarcinoma-intestine-pancreas/pancreatitis- associated protein (HIP/PAP) was found to be over-expressed more than 130-fold in pancreatic acinar cells in pancreatic cancer, as compared to normal pancreas. In contrast, only a 9-fold increased expression of HIP/PAP protein was observed in acinar cells in chronic pancreatitis. This offers a unique opportunity to image the tumor and tumor stromal interaction in pancreatic cancer. The objective of this exploratory project is to develop a highly sensitive HIP/PAP targeted molecular imaging agent based on a novel silicon hyperpolarized Magnetic Resonance Imaging (MRI) technique recently developed in my laboratory. Previous biochemical studies demonstrated that HIP/PAP protein is a "lactose binding protein" which has a very high affinity to D- lactose. We intend to employ lactose-functionalized hyperpolarized Silicon nanoparticles (SiNPs) to target HIP/PAP protein in the acinar cells surrounding the pancreatic tumor. Hyperpolarization leads to over 10,000 fold signal enhancement compared to conventional MRI. We hypothesize that the specificity of lactose- functionalized SiNPs binding to HIP/PAP surrounding the pancreatic cancer coupled with the sensitivity gain due to hyperpolarization will lead to an "effective lesion size amplification", thereby, enabling the visualization of pancreatic carcinoma in in vivo MRI with at least two to three orders of magnitude smaller than those currently detected. Towards this goal, we propose the following three specific aims: I. Optimize the levels of hyperpolarization achievable by radical-free 29Si Dynamic Nuclear Polarization on lactose-functionalized silicon nanoparticles (SiNPs) as a function of SiNP size and in vivo targeting efficacy. II. Demonstrate "effective lesion size amplification" with real-time hyperpolarized MRI in a) one orthotropic pancreatic tumor xenograft mouse model and in b) two cohorts of patient derived tumor engrafted into NOD/SCID mice one of which is na¿ve human pancreatic tumor and the other exposed to neoadjuvant therapy. III. Correlate hyperpolarized 29Si MR data acquired in Aims II with immunohistochemistry and optical imaging data of fluorescently-tagged SiNPs in the murine cancer models demonstrating efficacy of this technique on the detection pancreatic carcinoma with at least two to three orders of magnitude smaller than those currently detected.